A2 Milk: What It Is, What the Science Says, and Whether It's Worth the Premium

A2 milk is cow's milk that contains only the A2 variant of beta-casein protein, rather than the mixture of A1 and A2 beta-casein in standard commercial milk. The A2 Corporation (now The a2 Milk Company, listed on the ASX and NZX) commercialised the concept in New Zealand in 2000 and now sells products in the UK, Australia, the US, and China. UK A2 milk retails at approximately £1.90 to £2.50 per litre compared to £1.10 to £1.60 for standard whole milk. The premium rests on claims that A2 beta-casein is gentler on digestion than A1 beta-casein and may explain why some people who believe they are lactose intolerant feel better when switching to A2 milk. The science supports a genuine biological difference between A1 and A2 beta-casein digestion products; the clinical significance of this difference for most people remains actively debated and the evidence is based on a relatively small number of trials.

The A1 vs A2 Biology

Beta-casein is the second most abundant protein in cow's milk (approximately 30 to 35% of total milk protein). Two main genetic variants exist:

• A1 beta-casein: Has a histidine amino acid at position 67 of the protein chain. During digestion, this produces a seven-amino-acid fragment called BCM-7 (beta-casomorphin-7) more readily than A2.
• A2 beta-casein: Has a proline at position 67. The proline creates a structural constraint that resists the enzymatic cleavage that produces BCM-7; A2 beta-casein produces significantly less BCM-7 during human digestion.

BCM-7 is an opioid peptide with mu-opioid receptor binding activity. In preclinical research, BCM-7 has been associated with slowed intestinal transit time (which may cause bloating and constipation) and stimulation of mucus production in the gut. The hypothesis is that people who experience gastrointestinal discomfort after drinking standard milk but who are not actually lactose intolerant (confirmed by breath test or genetic testing) may be reacting to BCM-7 from A1 beta-casein rather than to lactose.

Historical context: dairy cattle breeds vary in their A1/A2 ratio. Most Asian cattle (Zebu, or Bos indicus breeds) and older European breeds (Guernsey, Jersey, Brown Swiss) produce predominantly A2 beta-casein. Modern high-yield Holstein Friesian and Ayrshire breeds (dominant in the UK and US) produce a mix of A1 and A2, with many individuals being A1/A1 homozygous. Historically, human populations in regions that consumed predominantly A2-producing breeds (much of Asia) would have had low exposure to A1 beta-casein.

The Research

The most cited clinical evidence for A2 milk's digestive benefits comes from trials conducted or funded by the a2 Milk Company:

• A 2016 study in European Journal of Clinical Nutrition (Barnett et al.) in 41 self-reported dairy-intolerant Chinese adults found that consumption of A1-containing milk was associated with significantly higher gastrointestinal symptoms (bloating, diarrhoea) and higher BCM-7 in stool samples compared to A2 milk consumption. This trial provided some of the strongest clinical evidence for the A1/A2 distinction in human subjects.
• A 2019 study in Nutrition Journal (Jianqin et al.) in 45 Chinese participants found that A2 milk consumption was associated with lower frequency of loose stools and reduced gastrointestinal discomfort compared to regular milk.
• A 2020 RCT in Nutrients (Deth et al.) found that children with self-reported dairy intolerance had improved gastrointestinal symptom scores and better cognitive performance scores on A2 milk versus regular milk, over a 2-week crossover period. Funding: the a2 Milk Company.

The limitations of the evidence: most trials are small (n=40 to 100), short-duration (2 to 4 weeks), and several were funded by or conducted in collaboration with the a2 Milk Company. Independent replications are limited. A 2019 systematic review in Nutrients (Truswell) concluded that while the trials were methodologically reasonable, the overall evidence base was insufficient to make population-level recommendations about A2 milk, and called for independent replication in larger trials.

Lactose Intolerance vs BCM-7 Sensitivity

A key practical question for individuals considering A2 milk is whether their dairy digestive issues are caused by lactose or by BCM-7 from A1 beta-casein. The distinction matters because:

• A2 milk contains the same amount of lactose as regular milk; it will not help people with confirmed lactose intolerance
• People who test negative for lactose malabsorption (via hydrogen breath test or genetic testing) but still experience dairy-related symptoms are the group most likely to benefit from A2 milk
• One study (Sebely Pal, 2015, in International Dairy Journal) estimated that approximately 20% of people who self-report lactose intolerance are actually reacting to A1 beta-casein rather than lactose, though this estimate has not been independently verified

A2 Milk Products in the UK

• a2 Milk UK: The a2 Milk Company's branded product, available in Tesco, Sainsbury's, ASDA, and other major supermarkets. Approximately £1.95 to £2.30 per litre for whole milk. Sourced from UK herds genetically tested and selected for A2/A2 homozygous beta-casein production.
• Guernsey and Jersey milk: These heritage breeds produce predominantly A2 beta-casein naturally (without specific A2 testing). Guernsey milk brands (Guernsey Farms Dairy) are available in some UK supermarkets and farmers' markets and may provide similar benefits at a comparable or lower premium.
• Goat's milk and sheep's milk: Both naturally contain predominantly A2 beta-casein and no A1 beta-casein. This may partially explain why some people who react to cow's milk tolerate goat's and sheep's milk better, though lactose content differs as well.

Related: Lactose Intolerance: How to Diagnose and Manage It | Goat's Milk vs Cow's Milk: Nutritional Differences and Digestive Properties